Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BH.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BL.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BA.2.75.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
B.1.160.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-4838.81South Korea
XBB.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.41EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EQ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JU.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DE.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BR.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used